Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, July 22, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/nlxhnm/nematicides) has announced the addition of the "Nematicides Market by Types,...
-
BOULDER, CO--(Marketwired - Jul 16, 2014) - AeroGrow International, Inc. (OTCQB: AERO) ("AeroGrow" or the "Company"), which sells the Miracle-Gro AeroGarden® line of high-output,...
-
BEVERLY, MA and TORONTO, ON--(Marketwired - Jul 16, 2014) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the...
-
Dublin, July 14, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/wbp9b2/herbicides_market) has announced the addition of the "International Herbicides...
-
VANCOUVER, British Columbia, July 9, 2014 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, announced today...
-
BEVERLY, MA and TORONTO, ON--(Marketwired - Jun 27, 2014) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the...
-
BEVERLY, MA and TORONTO, ON--(Marketwired - Jun 17, 2014) - Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision laser devices and advanced...
-
BEVERLY, MA and TORONTO, ON--(Marketwired - Jun 16, 2014) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the...
-
BEVERLY, MA and TORONTO, ON--(Marketwired - Jun 16, 2014) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the...
-
BOSTON, MA--(Marketwired - Jun 12, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announced...